Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma

NCT00753038 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Squamous Cell of the Head and Neck

Interventions

BIOLOGICAL: REOLYSIN®
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Oncolytics Biotech